OXISFORM 8-K

Company

GT Biopharma, Inc.

Filed

May 31, 2006

Period of Report

May 12, 2006

Accession Number

0000109657-06-000017

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →